Status:
COMPLETED
An Observational Study of Patients With Coronavirus Disease 2019
Lead Sponsor:
Target PharmaSolutions, Inc.
Conditions:
COVID-19
Coronavirus
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational study of patients with COVID-19 designed to specifically address important clinical questions that remain incompletely answered for coronavirus disease 2019.
Detailed Description
Data from up to 5,000 adult patients in the US will be captured from eligible patients enrolled following admission to the hospital. Participants will have de-identified medical records collected from...
Eligibility Criteria
Inclusion
- Adults (age ≥18 years) who are or have been hospitalized and diagnosed with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) infection.
- SARS-CoV-2 confirmed diagnosis (e.g. polymerase chain reaction \[PCR\] or other clinically utilized test).
Exclusion
- N/A
Key Trial Info
Start Date :
April 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 26 2022
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT04331886
Start Date
April 13 2020
End Date
September 26 2022
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98195